Golden State Wealth Management’s Sienna Biopharmaceuticals, Inc. SNNA Stock Holding History

Golden State Wealth Management’s Portfolio SNNA Stock Details SNNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-180,552	Closed	-$36K	–	1103
2019 Q3	$36K	Hold	180,552	–	–	0.01%	506
2019 Q2	$157K	Hold	180,552	–	–	0.05%	258
2019 Q1	$419K	Buy	+180,552	New	+$489K	0.14%	134

Other funds holding SNNA

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Private Ocean San Rafael, California $1.13B AUM 11.01% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Golden State Wealth Management's SNNA Position: Q4 2019 in Review

Golden State Wealth Management sold out of Sienna Biopharmaceuticals, Inc. (SNNA) in Q4 2019, closing a stake of 180,552 shares — an estimated $36K sold.

Golden State Wealth Management first reported a position in SNNA in Q1 2019 and held it in 3 quarters. The position peaked at $419K in Q1 2019. 4 funds tracked by Wall St. Rank hold SNNA as of Q4 2019.

Golden State Wealth Management reported no remaining Sienna Biopharmaceuticals, Inc. position as of Q4 2019 after selling out during the quarter.
Golden State Wealth Management sold 180,552 Sienna Biopharmaceuticals, Inc. shares in Q4 2019, an estimated $36K.
Golden State Wealth Management first reported a position in Sienna Biopharmaceuticals, Inc. in Q1 2019 and held it in 3 quarters.
Golden State Wealth Management's Sienna Biopharmaceuticals, Inc. position peaked at $419K in Q1 2019.
4 funds tracked by Wall St. Rank held Sienna Biopharmaceuticals, Inc. as of Q4 2019.

Based on Golden State Wealth Management's 13F filing for Q4 2019, filed 13 Feb 2020.